(Q39346309)

English

The prevalence of neutralising antibodies to chimpanzee adenovirus type 6 and type 7 in healthy adult volunteers, patients with chronic hepatitis B and patients with primary hepatocellular carcinoma in China

scientific article published on 22 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

The prevalence of neutralising antibodies to chimpanzee adenovirus type 6 and type 7 in healthy adult volunteers, patients with chronic hepatitis B and patients with primary hepatocellular carcinoma in China (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Li Jian

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Qiquan Zhao

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Shujun Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Wenxiang Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yujiao Xiong

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Xiangyang Zhou

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Bei Jia

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

22 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Archives of Virology

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

159

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

465-470

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Replication-defective vector based on a chimpanzee adenovirus

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Gene therapy: adenovirus vectors.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Gene vectors for cytokine expression in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Adenoviral vectors for gene therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Induction of balance and breadth in the immune response is beneficial for the control of SIVmac239 replication in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Construction of adenoviral vectors

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Novel adenoviruses in wild primates: a high level of genetic diversity and evidence of zoonotic transmissions

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Chimpanzee-origin adenovirus vectors as vaccine carriers.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Adenovirus 36 seropositivity is strongly associated with race and gender, but not obesity, among US military personnel

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1828-Y

21 January 2018

Identifiers

10.1007/S00705-013-1828-Y

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39346309&oldid=2202797488"